Iimpawu zoMsebenzi
Umda wokufumanisa: 5.0 mg / L;
Uluhlu lomgca: 5.0-200.0 mg / L;
I-coefficient yokulungelelanisa yomgca R ≥ 0.990;
Ukuchaneka: ngaphakathi kwe-batch CV ngu ≤ 15%;phakathi kweebhetshi iCV yi ≤ 20%;
Ukuchaneka: ukutenxa okunxulumeneyo kweziphumo zomlinganiselo akusayi kudlula ± 15% xa isilinganisi sokuchaneka esisemgangathweni sivavanywa.
1. Gcina i-detector buffer ku-2～30℃.Isithinteli sizinzile ukuya kwiinyanga ezili-18.
2. Gcina i-Aehealth Ferritin Rapid Quantitative test cassette kwi-2～30℃, ubomi beshelufu bufikelela kwiinyanga ezili-18.
3. Ikhasethi yovavanyo kufuneka isetyenziswe kwiyure enye emva kokuvula ipakethi.
I-Serum amyloid A (SAA) yiprotheyini ye-acute phase impendulo engacacanga, eyiprotheni ene-heterogeneous kwintsapho ye-apolipoprotein, kunye nobunzima be-molecular malunga ne-12,000.Kwimpendulo ye-acute phase, ekhuthazwa yi-IL-1, i-IL-6 kunye ne-TNF, i-SAA ihlanganiswe kwisibindi nge-macrophages esebenzayo kunye ne-fibroblasts, kwaye inokunyuswa ukuya kuma-100-1000 amaxesha oxinaniso lokuqala.I-Serum amyloid A inxulumene ne-high-density lipoprotein (i-HDL), enokulawula i-metabolism ye-high-density lipoprotein ngexesha lokuvuvukala.Eyona nto ibaluleke kakhulu kwi-serum amyloid A kukuba iimveliso zayo zokuthotywa zingafakwa kwizitho ezahlukeneyo ngendlela ye-amyloid A (AA) fibrils, eyona ngxaki inzima kwizifo ezingapheliyo ezivuthayo.Ixabiso layo leklinikhi njengophawu lokuvuvukala lifumene ingqwalasela ebanzi kwiminyaka yamuva.Utshintsho kumanqanaba e-SAA lunexabiso elibalulekileyo lonyango lokuxilonga kwangethuba, uvavanyo lomngcipheko, uqwalaselo olusebenzayo kunye novavanyo lweprognosis yezifo ezosulelayo.Ukongeza ekwandeni kosulelo lwebhaktiriya, i-SAA nayo yonyuka kakhulu kusulelo lwentsholongwane.Ngokweqondo lokunyuka okanye ngokudibanisa nezinye izibonakaliso, kunokubonisa ukusuleleka kwebhaktheriya okanye intsholongwane, ngaloo ndlela yenze ukungakwazi ukubonakaliswa kweempawu ezisetyenziswa ngokuqhelekileyo.Ukukhawulezisa ukunqongophala kosulelo lwentsholongwane.